• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,183.36 -135.03
( -0.18%)
Global Indices
Nasdaq
50,030.26 645.37
(1.31%)
Dow Jones
7,453.29 78.68
(1.07%)
Hang Seng
61,747.25 1,942.84
(3.25%)
Nikkei 225
10,425.97 95.42
(0.92%)
Forex
USD-INR
96.52 0.30
(0.32%)
EUR-INR
112.16 0.19
(0.17%)
GBP-INR
129.37 0.68
(0.52%)
JPY-INR
0.61 0.00
(0.22%)

EQUITY - MARKET SCREENER

Cash UR Drive Marketing Limited
Industry :  Miscellaneous
BSE Code
ISIN Demat
Book Value()
93511
INE0WL201014
64.6463748
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CUDML
15.28
254.28
EPS(TTM)
Face Value()
Div & Yield %
9.43
10
0
 

Bliss GVS Pharma consolidated net profit rises 128.96% in the March 2026 quarter
May 13,2026
Net profit of Bliss GVS Pharma rose 128.96% to Rs 35.58 crore in the quarter ended March 2026 as against Rs 15.54 crore during the previous quarter ended March 2025. Sales rose 29.80% to Rs 256.99 crore in the quarter ended March 2026 as against Rs 197.99 crore during the previous quarter ended March 2025.

For the full year,net profit rose 53.18% to Rs 129.13 crore in the year ended March 2026 as against Rs 84.30 crore during the previous year ended March 2025. Sales rose 14.50% to Rs 927.11 crore in the year ended March 2026 as against Rs 809.73 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales256.99197.99 30 927.11809.73 15
OPM %17.2910.65 -17.6915.65 -
PBDT53.5931.48 70 225.56155.06 45
PBT44.9223.44 92 192.08125.64 53
NP35.5815.54 129 129.1384.30 53